Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


De Smet, BE

Anneleen De Smet, Kruishoutem BE

Patent application numberDescriptionPublished
20090205955METHOD OF MANUFACTURING A ROTATABLE SPUTTER TARGET - The invention relates to a method to manufacture a rotatable sputter target. The method comprises the steps of—providing a backing tube;—providing a target material on the backing tube by coiling at least one elongated member around the backing tube;—providing an outer material on top of the target material;—applying heat and/or pressure to the outer material and/or to the backing tube;—removing the outer material.08-20-2009
20110239905 CORD FOR REINFORCEMENT OF A CEMENTITIOUS MATRIX - The invention relates a cord for the reinforcement of a cementitious matrix. The cord comprises number of coated metal filaments twisted together to form a cord. The cord shows cross-sections, whereby three or more of the filaments form a closed sub-structure having a void in the middle of the three or more filaments. The cord further comprises a protective compound whereby the protective compound is at least present in said void. The protective compound gives the coated metal element cathodic protection. The invention further relates to a structure comprising a number of cords such as a knitted, a braided, a welded or a glued structure. Furthermore the invention relates to a cementitious matrix reinforced with a cord according to the present invention and to a method to inhibit hydrogen gas evolution at the interface of a cord embedded in a cementitious matrix.10-06-2011

Charles De Smet, Brussels BE

Patent application numberDescriptionPublished
20080299078TUMOR ASSOCIATED AMINO ACIDS AND USES THEREFOR - The invention describes SAGE (sdph3.10) and sdp3.5 tumor associated nucleic acids, including fragments and biologically functional variants thereof. Also included are polypeptides and fragments thereof encoded by such nucleic acid molecules, and antibodies relating thereto. Methods and products also are provided for diagnosing and treating conditions characterized by expression of a sdph3.10 and/or sdp3.5 gene product.12-04-2008
20090274716LAGE-1 TUMOR ASSOCIATED NUCLEIC ACIDS - The invention describes the LAGE-1 tumor associated gene, including fragments, allelic variants and splice variants thereof. Also included are polypeptides and fragments thereof encoded by such genes, and antibodies relating thereto. Methods and products also are provided for diagnosing and treating conditions characterized by expression of a LAGE-1 gene product.11-05-2009

Patent applications by Charles De Smet, Brussels BE

Frederik De Smet, Leuven BE

Patent application numberDescriptionPublished
20120094864EXTRACELLULAR ALLOSTERIC INHIBITOR BINDING DOMAIN FROM A TYROSINE KINASE RECEPTOR - The present invention relates to an extracellular binding domain for an allosteric inhibitor, whereby said binding domain is derived from a single membrane span tyrosine kinase receptor. More specifically, the invention relates to an extracellular domain derived from a Fibroblast Growth Factor Receptor (FGFR). It further relates to the use of this domain for the identification of similar domains in the extracellular part of other tyrosine kinase receptors, and to a screening method for identification of a small compound allosteric inhibitor.04-19-2012

Herbert De Smet, Destelbergen BE

Patent application numberDescriptionPublished
20120062978METHOD FOR OPERATING A MICROMIRROR DEVICE WITH ELECTROMECHANICAL PULSE WIDTH MODULATION - A method of operating by pulse width modulation a micromirror device is disclosed. In one aspect, the method includes providing a micromirror device having a micromirror element electrostatically deflectable around a rotation axis between a first and second position. The micromirror element is controllable by applying voltage signals to a first and second electrode on one side of the rotation axis and a third and fourth electrode on the other side. The method includes associating an intermediate value of intensity to the micromirror element during a time frame, the intensity being between a first value corresponding to the first position and a second value corresponding to the second position. The method includes switching the micromirror element between the first and second position. The intermediate value corresponds to the ratio of periods in the time frame in which the micromirror element is in the first or second position.03-15-2012

Ive De Smet, Gent BE

Patent application numberDescriptionPublished
20090144860Genes involved in asymmetric cell division - The present invention relates to a method to isolate genes involved in the process of asymmetric cell division. The invention relates further to genes isolated using this method, and their use in controlling root formation, preferably lateral root formation.06-04-2009

Kris De Smet, Mol BE

Patent application numberDescriptionPublished
20090285890ANTIMICROBIAL PEROXIDASE COMPOSITIONS - The present invention discloses a class of compounds which have an enhancing effect on peroxidase based antimicrobial compositions. The invention relates to pharmaceutical compositions for prolonged topical use comprising enhancing agents such as methoxyphenols and substituted benzylaldehydes. Examples hereof are respectively guaiacol and vanillin.11-19-2009
20090317474USE OF POLYETHYLENE GLYCOL IN INFLAMMATION RELATED TOPICAL DISORDERS OR DISEASES AND WOUND HEALING - The present invention relates to hydrogel compositions or aqueous solutions comprising one or more forms of Poly-ethylene Glycol, for use as medicaments, more particularly for topical application in the treatment of wounds, for the treatment of inflammatory skin disease and in particular for the prevention of scar formation and/or for enhancing the repair of damaged skin or mucosa.12-24-2009

Peter De Smet, Sint-Martens-Latem BE

Patent application numberDescriptionPublished
20080289732ALUMINIUM-MAGNESIUM ALLOY PRODUCT - Method for making an aluminium-magnesium alloy in the form of a rolled product, having the composition in weight percent of: Mg 4.8-5.6, Mn 0.05-0.4, Zn 0.40-0.6, Cu 0.06-0.35, Cr 0.25 max., Fe 0.35 max., Si 0.25 max., Zr 0.12 max., Ti 0.3 max., others (each) max. 0.05, (total) max. 0.15, and balance aluminium.11-27-2008
20090169917ALUMINIUM COMPOSITE SHEET MATERIAL - Automotive body sheet in the form of an aluminium composite sheet material wherein a clad sheet is applied to at least one side of a core material, and wherein the core material is of an AA6xxx-series alloy, and wherein the clad sheet includes an AA5xxx-series alloy having less than 3.6 wt. % of Mg.07-02-2009
20090280352ALUMINIUM COMPOSITE SHEET MATERIAL - Automotive body sheet in the form of an aluminium composite sheet material wherein a clad sheet is applied to at least one side of a core material, and wherein the core material is of an aluminium alloy selected from the group consisting of aa2xxx, aa5xxx and aa7xxx-series alloys, and wherein the clad sheet includes an AA6xxx-series alloy having less than 0.2 wt. % Cu or an AA5xxx-series alloy having less than 3.6 wt. % of Mg.11-12-2009
20110250469ALUMINIUM COMPOSITE SHEET MATERIAL - Automotive body sheet in the form of an aluminium composite sheet material wherein a clad sheet is applied to at least one side of a core material, and wherein the core material is of an aluminium alloy selected from the group consisting of aa2xxx, aa5xxx and aa7xxx-series alloys, and wherein the clad sheet includes an AA6xxx-series alloy having less than 0.2 wt. % Cu or an AA5xxx-series alloy having less than 3.6 wt. % of Mg.10-13-2011

Patent applications by Peter De Smet, Sint-Martens-Latem BE